Are you sure you want to log out?
Molecular Targets of Cannabidiol in Neurological Disorders
CBD: A promising drug for neurodegenerative disorders?
CBDfor neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?
Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder
Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
CBDnormalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection
Cannabidiol, neuroprotection and neuropsychiatric disorders
Short-term effects of CBDafter global hypoxia-ischemia in newborn piglets
CBDreduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia
Short-term effects of cannabidiol after global hypoxia-ischemia in newborn piglets
CBDActivates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells
CBDreduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke
Interactions between CBDand THC following acute and repeated dosing
CBDattenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics & modulating glucose metabolism
Neurological aspects of medical use ofCBD
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid
1111 Brickell Avenue
Miami, FL 33131